Atrial Fibrillation
Friday, July 26th, 2013
American College of Cardiology Foundation: June 27, 2013 At last! For patients and doctors weary of monitoring INRs, a new host of long-anticipated oral anticoagulant therapies have joined warfarin and aspirin as excellent options in reducing the associated risk of thromboembolic stroke in atrial fibrillation. But which option is best? That, of course, depends on the […]
Atrial Fibrillation
Thursday, July 18th, 2013
Methods Used to Collect/Select the Evidence Hand-searches of Published Literature (Primary Sources) Hand-searches of Published Literature (Secondary Sources) Searches of Electronic Databases Description of Methods Used to Collect/Select the Evidence Note from the National Guideline Clearinghouse (NGC): The National Institute for Health and Clinical Excellence (NICE) commissioned an independent academic centre to perform a systematic […]
Atrial Fibrillation
Thursday, July 18th, 2013
Effective Healthcare: 6/28/13 This report is based on research conducted by the Duke Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2007-10066-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the […]
Atrial Fibrillation
Monday, July 15th, 2013
Wiley: JULY 9, 2013 Atrial fibrillation is associated with poorer outcomes poststroke. It is unclear how the quality of stroke care in hospitals influences outcomes in these patients. Aims The study aims to compare outcomes in stroke patients with and without atrial fibrillation and identify hospital processes of care associated with poor outcomes. Methods Data were […]
Atrial Fibrillation
Thursday, July 11th, 2013
JACC: July 2013 Objectives This study sought to determine whether ablation of recently described stable atrial fibrillation (AF) sources, either directly by Focal Impulse and Rotor Modulation (FIRM) or coincidentally when anatomic ablation passes through AF sources, may explain long-term freedom from AF. Background It is unclear why conventional anatomic AF ablation can be effective in some patients […]
Atrial Fibrillation
Thursday, July 11th, 2013
J Am Heart Assoc: 7/5/13 Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic Background While anticoagulation clinics have been shown to deliver tailored, high‐quality care to patients receiving warfarin therapy, communication barriers with limited English proficient (LEP) patients may lead to disparities in anticoagulation outcomes. Methods and Results We analyzed data […]
Atrial Fibrillation
Thursday, July 11th, 2013
Annals of Emergency Medicine: February 8, 2013 Study objective We aimed to describe the demographics, care, and outcomes of patients with atrial fibrillation in the emergency department (ED), as well as temporal changes over time. Methods In this retrospective cohort study, we used a province-wide database to identify all adult patients who were treated in a […]
Atrial Fibrillation
Thursday, July 11th, 2013
Journal of Neuroinflammation: June 28, 2013 Background Atrial fibrillation (AF) is associated with increased mortality and morbidity, including risk for cerebral macro- and microinfarctions and cognitive decline, even in the presence of adequate oral anticoagulation. AF is strongly related to increased inflammatory activity whereby anti-inflammatory agents can reduce the risk of new or recurrent AF. However, […]
Atrial Fibrillation
Thursday, June 27th, 2013
News-medical: June 25, 2013 Using catheter ablation to create complete linear lesions around pulmonary veins, proved more effective than the creation of incomplete lesions in preventing recurrence of atrial fibrillation (AF), reports the GAP-AF study. The study, presented today in the Late Breaking Clinical Trials session I at the EHRA EUROPACE 2013 meeting in Athens, Greece, represents the first time […]
Atrial Fibrillation
Thursday, June 27th, 2013
Neurology: 6/26/13 Objective: Antiplatelets are recommended for secondary prevention in patients with cryptogenic stroke; however, some patients may present with a cardioembolic source that has not been detected, which may modify the treatment. Because high pro–brain natriuretic peptide (BNP) levels are associated with cardioembolic stroke, our objective was to determine whether pro-BNP levels in the acute […]
